The Cigna Group (CI)
After hours:
| Previous Close | 352.28 |
| Open | 352.56 |
| Bid | 346.68 x 1000 |
| Ask | 354.51 x 1000 |
| Day's Range | 352.36 - 355.86 |
| 52 Week Range | 240.50 - 365.71 |
| Volume | |
| Avg. Volume | 1,544,801 |
| Market Cap | 100.556B |
| Beta (5Y Monthly) | 0.58 |
| PE Ratio (TTM) | 20.37 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 5.60 (1.59%) |
| Ex-Dividend Date | Mar 05, 2024 |
| 1y Target Est | N/A |
- PR Newswire
Evernorth announces Humira biosimilar available at $0 out of pocket for Accredo patients in June
In an important step toward driving long-term affordability and access to treatments for chronic and complex conditions, Evernorth Health Services announced that it will have a Humira® biosimilar available for $0 out of pocket for eligible patients of its specialty pharmacy Accredo beginning this June. The high- and low-concentration interchangeable biosimilar will be produced for Evernorth's affiliate private label pharmaceutical distributor, Quallent Pharmaceuticals, through agreements with mu
- Business Wire
AM Best Affirms Credit Ratings of The Cigna Group and Its Subsidiaries
OLDWICK, N.J., April 25, 2024--AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of "a+" (Excellent) of the key U.S. life/health subsidiaries and Europe-based insurance companies of The Cigna Group (Cigna) (headquartered in Bloomfield, CT) [NYSE: CI]. In addition, AM Best has affirmed the Long-Term ICR of "bbb+" (Good) and the Long-Term Issue Credit Ratings (Long-Term IRs) of Cigna. AM Best also has affirmed the Sho
- PR Newswire
The Cigna Group Declares Quarterly Dividend
The Board of Directors of The Cigna Group (NYSE: CI) today declared a cash dividend of $1.40 per share of its common stock, payable on June 20, 2024 to shareholders of record as of the close of business on June 4, 2024.
